Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US

摘要

BackgroundAlthough influenza vaccination has been shown to reduce the incidence of major adverse cardiac events (MACE) among those with existing cardiovascular disease (CVD), in the 2015–16 season, coverage for persons with heart disease was only 48% in the US.